Timber Pharmaceuticals Executives
TMBRDelisted Stock | USD 1.72 0.01 0.58% |
Timber Pharmaceuticals employs about 9 people. The company is managed by 3 executives with a total tenure of roughly 21 years, averaging almost 7.0 years of service per executive, having 3.0 employees per reported executive. Discussion of Timber Pharmaceuticals' management performance can provide insight into the enterprise performance.
Timber |
Timber Pharmaceuticals Management Team Effectiveness
The company has return on total asset (ROA) of (1.3727) % which means that it has lost $1.3727 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (3.4324) %, meaning that it created substantial loss on money invested by shareholders. Timber Pharmaceuticals' management efficiency ratios could be used to measure how well Timber Pharmaceuticals manages its routine affairs as well as how well it operates its assets and liabilities.Timber Pharmaceuticals Workforce Comparison
Timber Pharmaceuticals is rated below average in number of employees category among its peers. The total workforce of Health Care industry is at this time estimated at about 377. Timber Pharmaceuticals holds roughly 9.0 in number of employees claiming about 2.39% of equities under Health Care industry.
Timber Pharmaceuticals Insider Trading
Some recent studies suggest that insider trading raises the cost of capital for securities issuers and decreases overall economic growth. Trading by specific Timber Pharmaceuticals insiders, such as employees or executives, is commonly permitted as long as it does not rely on Timber Pharmaceuticals' material information that is not in the public domain. Local jurisdictions usually require such trading to be reported in order to monitor insider transactions. In many U.S. states, trading conducted by corporate officers, key employees, directors, or significant shareholders must be reported to the regulator or publicly disclosed, usually within a few business days of the trade. In these cases, Timber Pharmaceuticals insiders must file a Form 4 with the U.S. Securities and Exchange Commission (SEC) when buying or selling shares of their own companies.
Pirozzi Gianluca over a year ago Acquisition by Pirozzi Gianluca of 4100 shares of Timber Pharmaceuticals subject to Rule 16b-3 |
Timber Pharmaceuticals Notable Stakeholders
A Timber Pharmaceuticals stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as Timber Pharmaceuticals often face trade-offs trying to please all of them. Timber Pharmaceuticals' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting Timber Pharmaceuticals' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
About Timber Pharmaceuticals Management Performance
The success or failure of an entity such as Timber Pharmaceuticals often depends on how effective the management is. Timber Pharmaceuticals management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of Timber management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the Timber management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Timber Pharmaceuticals LLC, a clinical-stage biopharmaceutical company, engages in the development and commercialization of treatments for orphan dermatologic diseases. The company was founded in 2019 and is headquartered in Basking Ridge, New Jersey. Timber Pharmaceuticals operates under Biotechnology classification in the United States and is traded on AMEX Exchange. It employs 5 people.
Timber Pharmaceuticals Workforce Analysis
Traditionally, organizations such as Timber Pharmaceuticals use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare Timber Pharmaceuticals within its industry.Timber Pharmaceuticals Manpower Efficiency
Return on Timber Pharmaceuticals Manpower
Revenue Per Employee | 9.2K | |
Revenue Per Executive | 27.7K | |
Net Loss Per Employee | 2.2M | |
Net Loss Per Executive | 6.5M | |
Working Capital Per Employee | 530.2K | |
Working Capital Per Executive | 1.6M |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics. You can also try the Odds Of Bankruptcy module to get analysis of equity chance of financial distress in the next 2 years.
Other Consideration for investing in Timber Stock
If you are still planning to invest in Timber Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Timber Pharmaceuticals' history and understand the potential risks before investing.
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
Sync Your Broker Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors. | |
Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges |